The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. The post Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of…
Wearable technology seems to offer great potential for early detection and management of agitation experienced by people with communication-impaired neurological disorders, allowing caregivers to provide personalized interventions that could significantly improve patients’ lives. The post Digital Biomarkers in Agitation Detection: Enhancing Care for Communication-Impaired Neurological Disorders appeared first on MedCity News.
“An Arm and a Leg” senior producer Emily Pisacreta recently lost a job that provided her with health insurance. So now, for the first time, she will be signing up for Obamacare. Her search is off to a rocky start. Pisacreta gives listeners a sobering look at how the high price of health insurance plans…
Hooman Hakami, who has served as a senior executive at GE Healthcare and Medtronic, has been appointed CEO
New laws to curb aggressive hospital billing, to expand charity care for lower-income patients, and to rein in debt collectors have been enacted in more than 20 states since 2021. Democrats championed most measures. But the legislative efforts often passed with Republican support. The post Even Political Rivals Agree That Medical Debt Is an Urgent…
Joining Matthew Holt on #THCBGang on Monday December 16 at 1pm PST 4pm EST are patient safety expert Michael Millenson, physician, entrepreneur and technologist Shantanu Nundy; and Digital Health and Emerging Med-Tech Practice Co-Founder at Marsh & McLennan, Beracah Stortvedt. You can see the video below live (and later archived) & if you’d rather listen than…
California’s controversial experiment to order mental illness and drug treatment for some of its sickest residents is rolling out statewide, but the latest data shows the new initiative is falling far short of early objectives. The Community Assistance, Recovery and Empowerment Act — known as Care — recently expanded from 11 pilot counties to all…
With health officials reporting 800 measles cases in multiple states already this year, most of the public – and most parents – report hearing at least one false claim about measles or the vaccine for it, and many of them aren’t sure what to believe, the latest KFF Tracking Poll on Health Information and Trust…More
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. The post Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry appeared first on MedCity News.
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to review and potentially approve such treatments. The post Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions…